Homegrown private equity firm True North has entered into an agreement to acquire Glenmark Pharmaceuticals Ltd’s orthopaedic and pain management business for India and Nepal markets in a deal valued at about $92 million (Rs.635 cr.). Under the collaboration, Glenmark’s orthopaedic and pain management business will be transferred to a new entity to be incorporated by True North. The new entity – expected to be named Integrace Private Ltd – will market the product portfolio in India and Nepal.
True North buys Glenmark’s ortho, pain management business in $92 million deal
Date posted: Monday 13 August 2018